Quantum BioPharma's Unbuzzd Supplement Shows Significant Alcohol Metabolism Acceleration in Peer-Reviewed Clinical Trial
Key Insights
Quantum BioPharma's unbuzzd (search) dietary supplement demonstrated over 40% faster blood alcohol concentration reduction within 30 minutes compared to placebo in a double-blind, randomized clinical trial.
The study showed statistically significant improvements in alertness, reduced hangover (search) symptoms including 67% reduction in headache severity, and stabilization of heart rate and blood pressure changes from alcohol intoxication (search).
Published in the World Journal of Pharmaceutical and Medical Research, the trial challenges the long-held belief that alcohol metabolism cannot be significantly accelerated beyond the liver's natural processing rate.
Quantum BioPharma Ltd. has announced the peer-reviewed publication of clinical trial results demonstrating that its dietary supplement unbuzzd (search) significantly accelerates alcohol metabolism and reduces intoxication symptoms. The double-blind, randomized, placebo-controlled crossover study (NCT06505239) was published in the World Journal of Pharmaceutical and Medical Research, marking what the company describes as a challenge to centuries-old assumptions about alcohol processing.
Clinical Trial Design and Participants
The study was designed to mirror real-life scenarios where individuals would consume unbuzzd (search) after becoming intoxicated. Healthy male and female participants between ages 21 and 43, with weights ranging from 119 to 232 pounds, first consumed measured quantities of alcohol to achieve blood alcohol concentrations (BAC) between 0.07% and 0.11%. Following intoxication, participants received either unbuzzd or placebo, with researchers monitoring BAC levels, vital signs, and intoxication symptoms.
Accelerated Alcohol Metabolism Results
The most striking finding was unbuzzd (search)'s ability to dramatically reduce blood alcohol concentration. The supplement accelerated BAC reduction by more than 40% within the first 30 minutes compared to placebo, with this effect remaining statistically significant throughout the four-hour monitoring period. The acceleration was observed in both male and female participants.
"The science and medical communities for centuries have believed there is no way to significantly speed up alcohol metabolism once it is in your bloodstream; your liver processes it at a largely constant rate of approximately one standard drink per hour, and that the only sobering agent is time," said Anthony Durkacz, Founder and Executive Co-Chairman of Quantum BioPharma.
Cognitive and Physiological Improvements
Beyond metabolic effects, unbuzzd (search) demonstrated rapid improvements in cognitive function. Study participants reported statistically significant improvement in alertness within 30 minutes of consumption, making fewer cognitive errors compared to placebo results.
The supplement also addressed physiological changes associated with alcohol intoxication (search). Researchers observed statistically significant stabilization of heart rate elevation and blood pressure drops that typically accompany alcohol consumption.
Hangover Symptom Reduction
Participants experienced substantial hangover (search) relief, with statistically significant reductions in cognitive and physical impairment. Most notably, headache severity was reduced by 67% at four hours post-consumption, with benefits persisting at the eight-hour measurement point.
"The unbuzzd (search) clinical trial has now been published in a peer-reviewed international journal, and the trial confirms the exceptional overall efficacy of unbuzzd to help reduce the acute effects of alcohol intoxication (search) and hangover (search), all without causing adverse side effects," said Dr. Andrzej Chruscinski, Vice President of Clinical and Scientific Affairs at Quantum Biopharma.
Safety Profile
The supplement demonstrated an excellent safety profile, with all study participants tolerating unbuzzd (search) well and no reported adverse side effects throughout the trial period.
Commercial and Development Context
Unbuzzd (search) is formulated as a proprietary blend of vitamins, minerals, and herbs developed by Quantum BioPharma's scientific team. The formula is licensed to Unbuzzd Wellness Inc. (search), with Quantum BioPharma retaining 19.86% ownership and receiving 7% royalties on sales until reaching $250 million, after which royalties drop to 3% in perpetuity.
The company maintains 100% rights to develop similar products or alternative formulations specifically for pharmaceutical and medical applications, suggesting potential future development of prescription-grade alcohol metabolism enhancers.
Quantum BioPharma operates as a biopharmaceutical company focused on innovative assets for neurodegenerative and metabolic disorders, with unbuzzd (search) representing one component of its broader therapeutic portfolio that includes treatments for multiple sclerosis (search) through its subsidiary Lucid Psycheceuticals Inc. (search)